Skip to main content
ArticleOPEN ACCESS

Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8)

Orphanet Journal of Rare Diseases
DOI: 10.1186/s13023-022-02548-7
0Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following publication of the original article [1], we have been notified that there is a typographical error in the Fig. 1 text. It should be as per below: Figure 1: “111 patients received ≥ 1 risdiplam dose.

Cite

CITATION STYLE

APA

Hahn, A., Günther, R., Ludolph, A., Schwartz, O., Trollmann, R., Weydt, P., … Hagenacker, T. (2022, December 1). Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany (Orphanet Journal of Rare Diseases, (2022), 17, 1, (276), 10.1186/s13023-022-02420-8). Orphanet Journal of Rare Diseases. BioMed Central Ltd. https://doi.org/10.1186/s13023-022-02548-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free